Safety assessment of niacin in the US Food and Drug Administration's mini‐sentinel system

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1557|27|1|30-37

ISSN： 1053-8569

Source： PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol.27, Iss.1, 2018-01, pp. : 30-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liver injury with novel oral anticoagulants: assessing post‐marketing reports in the US Food and Drug Administration adverse event reporting system

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 2, 2015-08 ,pp. : 285-293

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Precautionary Principle and the Regulation of U.S. Food and Drug Safety

By Soule Ed  

The Journal of Medicine and Philosophy, Vol. 29, Iss. 3, 2004-06 ,pp. : 333-350

Oxford University Press

Access to resources Recommend Favorite

Comparison of oncology drug approval between Health Canada and the US Food and Drug Administration

By  

CANCER, Vol. 121, Iss. 10, 2015-05 ,pp. : 1688-1693

John Wiley & Sons Inc

Access to resources Recommend Favorite

Complementary use of passive surveillance and Mini‐Sentinel to better characterize hemolysis after immune globulin

By  

TRANSFUSION, Vol. 55, Iss. S2, 2015-07 ,pp. : S28-S35

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pain palliation measurement in cancer clinical trials: The US Food and Drug Administration perspective

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 761-767

John Wiley & Sons Inc

Access to resources Recommend Favorite